Literature DB >> 23396964

HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.

John S Witte1, Joel Mefford, Sarah J Plummer, Jinghua Liu, Iona Cheng, Eric A Klein, Benjamin A Rybicki, Graham Casey.   

Abstract

BACKGROUND: Recent work detected for the first time a high-risk prostate cancer mutation, in homeobox B13 (HOXB13) among European-Americans.
METHODS: We further evaluated this G84E missense mutation (rs138213197) in two genetic association studies of prostate cancer: a family-based study of brothers and a case-control study of more aggressive disease (N = 2,665 total). We then calculated overall impact of this mutation by pooling all published studies of European-Americans.
RESULTS: In our studies, the mutation was found exclusively among men with prostate cancer (carrier frequency = 1.48%) or unaffected brothers of cases carrying the mutation (frequency = 0.34%), and carrying the mutation gave an OR for disease = 4.79 (P = 0.01). The G84E mutation was more common among men with an earlier age of onset (≤55 years) or a family history of prostate cancer. We also observed for the first time an African-American case carrying the G84E mutation, although at HOXB13 both of his chromosomes were of European-American ancestry. The pooled analysis also indicated that carrying the G84E mutation results in an almost five-fold increase in risk of prostate cancer (P = 3.5 × 10(-17)), and this risk is even higher among cases with an early age of prostate cancer onset (≤55 years) or a family history of disease: a test of heterogeneity across these strata gives P < 1 × 10(-5).
CONCLUSIONS: The HOXB13 mutation substantially increases risk of early onset, familial prostate cancer in European-American men. IMPACT: Testing for the G84E mutation in men with a positive family history may help distinguish those who merit more regular screening for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396964      PMCID: PMC3617049          DOI: 10.1158/1055-9965.EPI-12-1154

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Genome-wide association studies and beyond.

Authors:  John S Witte
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

Review 2.  Human HOX gene mutations.

Authors:  F R Goodman; P J Scambler
Journal:  Clin Genet       Date:  2001-01       Impact factor: 4.438

3.  Germline mutations in HOXB13 and prostate-cancer risk.

Authors:  Charles M Ewing; Anna M Ray; Ethan M Lange; Kimberly A Zuhlke; Christiane M Robbins; Waibhav D Tembe; Kathleen E Wiley; Sarah D Isaacs; Dorhyun Johng; Yunfei Wang; Chris Bizon; Guifang Yan; Marta Gielzak; Alan W Partin; Vijayalakshmi Shanmugam; Tyler Izatt; Shripad Sinari; David W Craig; S Lilly Zheng; Patrick C Walsh; James E Montie; Jianfeng Xu; John D Carpten; William B Isaacs; Kathleen A Cooney
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

4.  A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.

Authors:  Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; Tim Bishop; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Chih-Lin Hsieh; Jerry Halpern; Raymond N Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Stephen N Thibodeau; Shannon K McDonnell; Julie M Cunningham; Katherine E Zarfas; Scott Hebbring; Daniel J Schaid; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Michael Badzioch; Gail P Jarvik; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Ethan M Lange; Jennifer L Beebe-Dimmer; Caroline E Mohai; Kathleen A Cooney; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo Lj Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Bjorn-Anders Jonsson; Henrik Gronberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; Daniela Seminara
Journal:  Am J Hum Genet       Date:  2005-06-29       Impact factor: 11.025

5.  A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

Authors:  Robert Karlsson; Markus Aly; Mark Clements; Lilly Zheng; Jan Adolfsson; Jianfeng Xu; Henrik Grönberg; Fredrik Wiklund
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

6.  HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.

Authors:  Young-Rang Kim; Kyung-Jin Oh; Ra-Young Park; Nguyen Thi Xuan; Taek-Won Kang; Dong-Deuk Kwon; Chan Choi; Min Soo Kim; Kwang Il Nam; Kyu Youn Ahn; Chaeyong Jung
Journal:  Mol Cancer       Date:  2010-05-27       Impact factor: 27.401

7.  Combined genome-wide scan for prostate cancer susceptibility genes.

Authors:  Elizabeth M Gillanders; Jianfeng Xu; Bao-li Chang; Ethan M Lange; Fredrik Wiklund; Joan E Bailey-Wilson; Agnes Baffoe-Bonnie; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Sarah D Isaacs; Kathleen E Wiley; Caroline E Mohai; Mika P Matikainen; Teuvo L J Tammela; S Lilly Zheng; W Mark Brown; Annika Rökman; John D Carpten; Deborah A Meyers; Patrick C Walsh; Johanna Schleutker; Henrik Gronberg; Kathleen A Cooney; William B Isaacs; Jeffrey M Trent
Journal:  J Natl Cancer Inst       Date:  2004-08-18       Impact factor: 13.506

8.  HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4.

Authors:  Chaeyong Jung; Ran-Sook Kim; Sang-Jin Lee; Chihuei Wang; Meei-Huey Jeng
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

9.  The homeodomain protein HOXB13 regulates the cellular response to androgens.

Authors:  John D Norris; Ching-Yi Chang; Bryan M Wittmann; Rebecca S Kunder; Huaxia Cui; Daju Fan; James D Joseph; Donald P McDonnell
Journal:  Mol Cell       Date:  2009-11-13       Impact factor: 17.970

10.  Association of a HOXB13 variant with breast cancer.

Authors:  Shaheen Alanee; Fergus Couch; Kenneth Offit
Journal:  N Engl J Med       Date:  2012-08-02       Impact factor: 91.245

View more
  23 in total

1.  G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.

Authors:  Hang Huang; Bing Cai
Journal:  Tumour Biol       Date:  2013-09-13

2.  Familial prostate cancer.

Authors:  Veda N Giri; Jennifer L Beebe-Dimmer
Journal:  Semin Oncol       Date:  2016-08-18       Impact factor: 4.929

3.  The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Authors:  Jennifer L Beebe-Dimmer; Matthew Hathcock; Cecilia Yee; Linda A Okoth; Charles M Ewing; William B Isaacs; Kathleen A Cooney; Stephen N Thibodeau
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-24       Impact factor: 4.254

Review 4.  Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Authors:  Veda N Giri; Karen E Knudsen; William K Kelly; Wassim Abida; Gerald L Andriole; Chris H Bangma; Justin E Bekelman; Mitchell C Benson; Amie Blanco; Arthur Burnett; William J Catalona; Kathleen A Cooney; Matthew Cooperberg; David E Crawford; Robert B Den; Adam P Dicker; Scott Eggener; Neil Fleshner; Matthew L Freedman; Freddie C Hamdy; Jean Hoffman-Censits; Mark D Hurwitz; Colette Hyatt; William B Isaacs; Christopher J Kane; Philip Kantoff; R Jeffrey Karnes; Lawrence I Karsh; Eric A Klein; Daniel W Lin; Kevin R Loughlin; Grace Lu-Yao; S Bruce Malkowicz; Mark J Mann; James R Mark; Peter A McCue; Martin M Miner; Todd Morgan; Judd W Moul; Ronald E Myers; Sarah M Nielsen; Elias Obeid; Christian P Pavlovich; Stephen C Peiper; David F Penson; Daniel Petrylak; Curtis A Pettaway; Robert Pilarski; Peter A Pinto; Wendy Poage; Ganesh V Raj; Timothy R Rebbeck; Mark E Robson; Matt T Rosenberg; Howard Sandler; Oliver Sartor; Edward Schaeffer; Gordon F Schwartz; Mark S Shahin; Neal D Shore; Brian Shuch; Howard R Soule; Scott A Tomlins; Edouard J Trabulsi; Robert Uzzo; Donald J Vander Griend; Patrick C Walsh; Carol J Weil; Richard Wender; Leonard G Gomella
Journal:  J Clin Oncol       Date:  2017-12-13       Impact factor: 44.544

5.  Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.

Authors:  Elizabeth Handorf; Nicole Crumpler; Laura Gross; Veda N Giri
Journal:  J Genet Couns       Date:  2013-12-07       Impact factor: 2.537

Review 6.  Prostate cancer in young men: an important clinical entity.

Authors:  Claudia A Salinas; Alex Tsodikov; Miriam Ishak-Howard; Kathleen A Cooney
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

7.  Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

Authors:  Jennifer L Beebe-Dimmer; William B Isaacs; Kimberly A Zuhlke; Cecilia Yee; Patrick C Walsh; Sarah D Isaacs; Anna M Johnson; Charles E Ewing; Elizabeth B Humphreys; Wasim H Chowdhury; James E Montie; Kathleen A Cooney
Journal:  BJU Int       Date:  2014-03-05       Impact factor: 5.588

8.  Prostate cancer risk variants of the HOXB genetic locus.

Authors:  William D Dupont; Joan P Breyer; Spenser H Johnson; W Dale Plummer; Jeffrey R Smith
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.996

9.  Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Authors:  Thomas J Hoffmann; Lori C Sakoda; Ling Shen; Eric Jorgenson; Laurel A Habel; Jinghua Liu; Mark N Kvale; Maryam M Asgari; Yambazi Banda; Douglas Corley; Lawrence H Kushi; Charles P Quesenberry; Catherine Schaefer; Stephen K Van Den Eeden; Neil Risch; John S Witte
Journal:  PLoS Genet       Date:  2015-01-28       Impact factor: 5.917

10.  HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.

Authors:  Steven C Smith; Nallasivam Palanisamy; Kimberly A Zuhlke; Anna M Johnson; Javed Siddiqui; Arul M Chinnaiyan; Lakshmi P Kunju; Kathleen A Cooney; Scott A Tomlins
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.